These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 10440585)
1. Binding of antiarrhythmic drugs to human placenta in vitro. Bailey DN Ann Clin Lab Sci; 1999; 29(3):209-12. PubMed ID: 10440585 [TBL] [Abstract][Full Text] [Related]
2. The binding of acetaminophen, lidocaine, and valproic acid to human milk. Bailey DN; Briggs JR Am J Clin Pathol; 2004 May; 121(5):754-7. PubMed ID: 15151216 [TBL] [Abstract][Full Text] [Related]
3. [The interaction of antiarrhythmic drugs with other drugs]. Yamaguchi I Kokyu To Junkan; 1985 Aug; 33(8):956-69. PubMed ID: 2866571 [No Abstract] [Full Text] [Related]
4. Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs. Hasannejad H; Takeda M; Narikawa S; Huang XL; Enomoto A; Taki K; Niwa T; Jung SH; Onozato ML; Tojo A; Endou H Eur J Pharmacol; 2004 Sep; 499(1-2):45-51. PubMed ID: 15363950 [TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of bunaftine, a new antiarrhythmic agent: comparison with quinidine, ajmaline, procainamide, xylocaine and propranolol. Castellucci A Arzneimittelforschung; 1976 Feb; 26(2):241-4. PubMed ID: 947206 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic drugs: electrophysiological and pharmacokinetic considerations. Sasyniuk BI; Ogilvie RI Annu Rev Pharmacol; 1975; 15():131-55. PubMed ID: 1096787 [No Abstract] [Full Text] [Related]
8. Effects of lidocaine, procaine, procainamide and quinidine on electrophysiological properties of cultured embryonic chick hearts. Riccioppo Neto FR; Sperelakis N Br J Pharmacol; 1985 Dec; 86(4):817-26. PubMed ID: 4075018 [TBL] [Abstract][Full Text] [Related]
9. [Mode of action of antiarrhythmic drugs (author's transl)]. Sano T Kokyu To Junkan; 1974 Apr; 22(4):321-6. PubMed ID: 4603686 [No Abstract] [Full Text] [Related]
10. Morphological changes in human erythrocytes induced in vitro by antiarrhythmic drugs. Suwalsky M; Villena F Cell Mol Biol (Noisy-le-grand); 1995 Mar; 41(2):307-12. PubMed ID: 7787741 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of some antiarrhythmic drugs. Ochs HR; Greenblatt DJ; Bodem G Herz; 1979 Aug; 4(4):330-43. PubMed ID: 391683 [No Abstract] [Full Text] [Related]
12. Metabolites of antiarrhythmic drugs: are they clinically important? Kates RE Ration Drug Ther; 1986 May; 20(5):1-5. PubMed ID: 3097754 [No Abstract] [Full Text] [Related]
13. Effect of antiarrhythmic agents on cardiac metabolism. Belliveau RE; Covino BG Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):130-8. PubMed ID: 5650322 [No Abstract] [Full Text] [Related]
16. Factors influencing serum protein binding of lidocaine in humans. McNamara PJ; Slaughter RL; Pieper JA; Wyman MG; Lalka D Anesth Analg; 1981 Jun; 60(6):395-400. PubMed ID: 6165258 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic therapy of ventricular arrhythmias. Winkle RA; Glantz SA; Harrison DC Am J Cardiol; 1975 Oct; 36(5):629-50. PubMed ID: 1103605 [TBL] [Abstract][Full Text] [Related]
18. A screening method for antiarrhythmic agents in the rat. Garland L; Walker JM Br J Pharmacol; 1970 May; 39(1):229P. PubMed ID: 5420120 [No Abstract] [Full Text] [Related]